Shanghai Junshi Biosciences Announces Board and Committees
PremiumCompany AnnouncementsShanghai Junshi Biosciences Announces Board and Committees
18d ago
Shanghai Junshi Biosciences to Review Financial Results
Premium
Company Announcements
Shanghai Junshi Biosciences to Review Financial Results
24d ago
Shanghai Junshi’s Toripalimab Gains Approval in Hong Kong
Premium
Company Announcements
Shanghai Junshi’s Toripalimab Gains Approval in Hong Kong
26d ago
Junshi Biosciences Major Shareholders Plan to Reduce Stakes
PremiumCompany AnnouncementsJunshi Biosciences Major Shareholders Plan to Reduce Stakes
2M ago
Toripalimab Gains EC Approval for Cancer Treatment
Premium
Company Announcements
Toripalimab Gains EC Approval for Cancer Treatment
2M ago
Junshi Biosciences Reports H1 2024 Fund Management
Premium
Company Announcements
Junshi Biosciences Reports H1 2024 Fund Management
2M ago
Junshi Biosciences Advances Melanoma Treatment
PremiumCompany AnnouncementsJunshi Biosciences Advances Melanoma Treatment
3M ago
Junshi Biosciences’ Drug Nears EU Approval
Premium
Company Announcements
Junshi Biosciences’ Drug Nears EU Approval
4M ago
Shanghai Junshi’s New Cancer Drug Application Accepted
Premium
Company Announcements
Shanghai Junshi’s New Cancer Drug Application Accepted
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100